Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or delivering the wrong diagnosis.

Is the Galleri multi-cancer blood test worth it? A doctor explains real-world performance data and explains why no major ...

Private companies are capitalizing on this quest for information. Grail’s Galleri blood test screens for more than 50 ...

Colorectal cancer is highly treatable when caught early—and FIT tests make screening easier than ever with a simple at‑home ...

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease.

Despite efforts by test maker Grail to highlight outcomes the company considers positive, some experts are warning against using the Galleri test and others like it.

Colorectal cancer is one of the cancers where, if found early, it has a 91% chance of survival for the patient. If you find ...

A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. A new blood test that ...

For asymptomatic people without known risks, the downsides and uncertainties of multi-cancer early detection testing could ...

The firefighters union in Kentwood held an event Thursday providing precancer screenings using a DNA test. The U.S. Fire ...

Disney alum Christy Carlson Romano is getting candid about a frightening new health scare. The “Even Stevens” star revealed ...

China’s health ministry urged people at potential risk to undergo cancer screenings as part of a broader push to improve prevention and control of the disease.